Quantum motion of methyl groups in solids

Available from British Library Lending Division - LD:D55316/85 / BLDSC - British Library Document Supply CentreSIGLEGBUnited Kingdo

Performance of Lactating Dairy Cows Fed Dried Sardines

To utilize locally available feed resources with livestock production in hot climates, dried sardines were incorporated into diets for lactating dairy cows. Fourteen Holstein and 13 Australian Milk Zebu multiparous cows were used in a 70-day continuous feeding experiment. lsonitrogenous and isoenergetic diets containing either soybean meal or dried sardines (supplied 40% of dietary crude protein) were fed ad - libitum. Comparisons between diets were made during the 7-week experimental period. The experiment was conducted as a 2 x 2 factorial arrangement of treatment, with diet and breed as main factors. Ruminal pH, ammonia N, total and individual volatile fatty acids concentrations were not altered by the feeding of dried sardines. Intakes of dry matter, energy, crude protein, and acid detergent fiber were lower (P0.05) in Holstein cows fed dried sardines than those fed the control diet (16.2 vs 15.1 kg/d). Feeding of dried sardines did not affect milk composition and compositional yields. Milk production was higher (P<0.01) in Holstein than Australian Milk Zebu cows. Effect of diet and breed interaction on milk production was significant (P<0.01 ). Potential of feeding marine proteins may be higher for higher milk producers (Holstein) than lower producers (Australian Milk Zebu). Reproduction parameters, body condition scores, and heat-stress associated parameters were not affected by the feeding of dried sardines. This study suggests that dried sardines could be incorporated into diets of lactating dairy cows without affecting milk production

Efeito dos níveis de concentrado sobre as características de carcaça de ovinos Morada Nova em confinamento Effect of concentrate levels on carcass characteristics of the Morada Nova breed sheep in feedlot

Avaliaram-se as características de carcaça e os rendimentos dos cortes medidos in vivo e na carcaça de ovinos Morada Nova terminados em confinamento com dietas contendo diversos níveis de concentrado. Utilizaram-se 32 cordeiros castrados, Morada Nova, com 8,11 ± 1,15 meses de idade e peso inicial de 19,67 ± 2,97 kg, em delineamento de blocos casualizados, cada um com oito repetições. Os animais foram abatidos com 30,0 kg e alimentados com quatro níveis de concentrado (20, 40, 60 ou 80%). Houve efeito linear crescente do nível de concentrado da dieta sobre o peso do corpo vazio e peso e o rendimento da carcaça fria e efeito linear decrescente sobre o conteúdo do trato digestório e o número de dias em confinamento. Os níveis de concentrado tiveram efeito linear crescente sobre o peso e rendimento de pescoço e efeito linear decrescente sobre os rendimentos da paleta e perna, ao passo que o peso do costilhar foi influenciado de forma quadrática pelos tratamentos. Nas medidas in vivo, apenas o perímetro da perna sofreu efeito decrescente. Nas medidas na carcaça, houve efeito linear crescente sobre a largura do tórax e a compacidade, que aumentaram com o nível de concentrado na dieta, enquanto a largura da garupa teve efeito quadrático. O uso de concentrado na dieta eleva os pesos e os rendimentos de carcaça fria, mas não aumenta os pesos e rendimentos dos cortes da carcaça de cordeiros Morada Nova.<br>The in vivo carcass characteristics and the cut yields measured in the carcass of Morada Nova sheep finished in feedlot system fed increasing levels of dietary concentrate were evaluated. Thirty-two castrated Morada Nova lambs with 8.11 ± 1.15 months of age and 19.67 ± 2.97 kg of initial body weight were used in this trial. The experimet was analyzed as a completely randomized block design with eight replicates per treatment. Animals were slaughtered at 30.0 kg BW and fed diets with four concentrate levels: 20, 40, 60 or 80%. Linear increasing effect of dietary concentrate on empty body weight and cold carcass weight and yield and linear decreasing effect on digestive tract content and feedlot period were observed. The neck weight and yield linearly increased and the percentage of shoulder and leg linearly decreased with the concentrate levels, while the rib weight showed quadratic effect. In the in vivo measurements, only leg perimeter presented significant effect. There was a linear increasing effect for thoracic width and carcass compactness, while the hind width showed quadratic effect. The use of concentrate in the diet increased the weight and yields of cold carcass; however this maximization did not increase the weights and yields of commercial cuts from Morada Nova lambs

Posaconazole treatment of refractory eumycetoma and chromoblastomycosis Tratamento com posaconazol de casos de cromoblastomicose e micetoma maduromicótico resistentes a outros antifúngicos

Eumycetoma and chromoblastomycosis are chronic, disfiguring fungal infections of the subcutaneous tissue that rarely resolve spontaneously. Most patients do not achieve sustained long-term benefits from available treatments; therefore, new therapeutic options are needed. We evaluated the efficacy of posaconazole, a new extended-spectrum triazole antifungal agent, in 12 patients with eumycetoma or chromoblastomycosis refractory to existing antifungal therapies. Posaconazole 800 mg/d was given in divided doses for a maximum of 34 months. Complete or partial clinical response was considered a success; stable disease or failure was considered a nonsuccess. All 12 patients had proven infections refractory to standard therapy. Clinical success was reported for five of six patients with eumycetoma and five of six patients with chromoblastomycosis. Two patients were reported to have stable disease. As part of a treatment-use extension protocol, two patients with eumycetoma who initially had successful outcome were successfully retreated with posaconazole after a treatment hiatus of > 10 months. Posaconazole was well tolerated during long-term administration (up to 1015 d). Posaconazole therapy resulted in successful outcome in most patients with eumycetoma or chromoblastomycosis refractory to standard therapies, suggesting that posaconazole may be an important treatment option for these diseases.<br>Eumicetoma e cromoblastomicose são infecções fúngicas crônicas do tecido subcutâneo que evoluem com aspecto desfigurado, raramente involuindo espontaneamente. A maioria dos pacientes não apresenta melhora sustentada por longo tempo com os tratamentos disponíveis, sendo de grande importância as novas opções terapêuticas. A eficácia do posaconazol, um novo agente antifúngico de amplo espectro do grupo dos triazóis, foi estudada em 12 pacientes com eumicetoma ou cromoblastomicose refratária às terapêuticas antifúngicas disponíveis. Os pacientes receberam por no máximo 34 meses, doses divididas de 800 mg/dia de posaconazol. Resposta clínica parcial ou completa foi considerada como sucesso; doença estável ou falha terapêutica foi considerada como insucesso. Todos os 12 pacientes tinham infecções comprovadas ou prováveis, refratárias à terapêutica padrão preconizada. Sucesso clínico foi registrado em cinco de seis pacientes com eumicetoma e cinco de seis pacientes com cromoblastomicose. Em dois pacientes observou-se doença estável. Como parte do protocolo de extensão do tratamento, dois pacientes com eumicetoma que inicialmente tinham tido sucesso terapêutico e que após um intervalo maior de 10 meses apresentaram recidiva da micose, foram retratados com sucesso com posaconazol. Posaconazol foi bem tolerado durante o longo período de administração (até 1015 dias). A terapêutica com posaconazol foi seguida de sucesso na maioria dos pacientes com eumicetoma ou cromoblastomicose refratária à terapêutica padrão, sugerindo que tal droga possa ser uma importante opção no tratamento de tais doenças